GSK's number of employees by region 2011-2022
In 2011, the number of GSK (GlaxoSmithKline) employees in Europe totaled about 38.7 thousand. The number of employees in Europe increased to almost 44 thousand in 2015, but dropped since then back to some 31,800. GSK is among the top global pharmaceutical companies alongside companies like Roche, Pfizer and AstraZeneca.
GlaxoSmithKline’s pharmaceuticals
GlaxoSmithKIine is a global pharmaceutical manufacturer and developer that creates medicines, vaccinations and consumer health products. In 2020, GlaxoSmithKline was among the global top ten pharmaceutical companies based on pharmaceutical sales. GlaxoSmithKline has many kinds of pharmaceuticals available and they excel in certain sectors, such as respiratory pharmaceuticals. As an example, Advair, a respiratory pharmaceutical product marketed by GlaxoSmithKline, is among the top respiratory medications based on revenue.
GlasxoSmithKline’s global revenue
From 2006 to 2021, GlaxoSmithKline’s revenues generally saw some ups and downs with growth in more recent years. GlaxoSmithKline has numerous sectors and divisions within the company. Within those sectors, pharmaceuticals and vaccines have provided a significant proportion of the company’s yearly revenues. GlaxoSmithKline’s revenue is regionally variable. As of 2022, the United States accounts for the largest proportion of GlaxoSmithKline’s revenue.
GlaxoSmithKline’s pharmaceuticals
GlaxoSmithKIine is a global pharmaceutical manufacturer and developer that creates medicines, vaccinations and consumer health products. In 2020, GlaxoSmithKline was among the global top ten pharmaceutical companies based on pharmaceutical sales. GlaxoSmithKline has many kinds of pharmaceuticals available and they excel in certain sectors, such as respiratory pharmaceuticals. As an example, Advair, a respiratory pharmaceutical product marketed by GlaxoSmithKline, is among the top respiratory medications based on revenue.
GlasxoSmithKline’s global revenue
From 2006 to 2021, GlaxoSmithKline’s revenues generally saw some ups and downs with growth in more recent years. GlaxoSmithKline has numerous sectors and divisions within the company. Within those sectors, pharmaceuticals and vaccines have provided a significant proportion of the company’s yearly revenues. GlaxoSmithKline’s revenue is regionally variable. As of 2022, the United States accounts for the largest proportion of GlaxoSmithKline’s revenue.
